# DESCRIPTION

## TECHNICAL FIELD

- define technical field

## BACKGROUND

- describe viral hemorrhagic fever
- describe Ebola hemorrhagic fever

## SUMMARY

- state technical problem
- introduce berbamine dihydrochloride
- describe use of berbamine dihydrochloride
- describe virus inhibitor
- describe product for treating/preventing viral hemorrhagic fever
- describe product binding to primed viral glycoprotein
- describe carrier materials
- describe dosage forms
- describe pharmaceutical compound
- describe method for inhibiting virus
- describe method for treating/preventing viral hemorrhagic fever

## DETAILED DESCRIPTION

- introduce experimental methods and materials
- describe berbamine dihydrochloride and its acquisition
- summarize predecessors' studies on Ebola virus
- outline the present invention's drug design method

### Embodiment 1. Verification of Berbamine Dihydrochloride being Capable of Specifically Inhibit the Activity of EBOV by Using a Screening Model for an EBOV Entry Inhibitor

- prepare recombinant virus EBOV-Zaire GP/HIV-luc
- evaluate antiviral activity of compounds using luciferase activity
- analyze specificity of compounds using VSVG-expressing pseudovirus VSV-G/HIV-luc
- conduct experiment in triplicate and show results in FIG. 2
- conclude berbamine dihydrochloride has specific inhibition effect on EBOV-Zaire GP/HIV-luc

### Embodiment 2: The Antiviral Activity of Berbamine Dihydrochloride Having Nothing to do with its Cytotoxicity

- evaluate effect of berbamine dihydrochloride on 293T cell growth using CCK-8 kit
- conclude antiviral activity of berbamine dihydrochloride has nothing to do with its cytotoxicity

### Embodiment 3. Berbamine Dihydrochloride Having a Good Dose-Dependent Inhibition Effect on EBOV

- evaluate dose-dependent inhibition effect of berbamine dihydrochloride on EBOV-Zaire GP/HIV-luc

### Embodiment 4: Berbamine Dihydrochloride Acting on the Entering Stage of a Virus, as Determined by a Drug TOA Experiment

- conduct drug TOA experiment to study acting phase of berbamine dihydrochloride
- conclude berbamine dihydrochloride acts on the entering stage of a virus

### Embodiment 5. Evaluation of Compounds Using Marburg Recombinant Virus and Lassa Recombinant Virus Models

- establish Marburg and Lassa recombinant virus models
- evaluate antiviral activity of berbamine dihydrochloride against Marburg and Lassa viruses

### Embodiment 6. Determination of the Capability of Berbamine Dihydrochloride of Binding to the Target Protein GPcl In Vitro by Using a BioLayer Interferometry Technology

- describe experimental setup
- detail binding assay protocol
- analyze experimental results
- generalize to other viruses

